Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products

ABSTRACT

Compositions comprising one or more chelating agents and optionally zinc ion salts are used to inhibit the growth or biofilm formation in bacteria associated with personal care products such as ophthalmic, pedicure, manicure or podiatric solutions. The compositions of the present application can also comprise gelling agents, antimicrobials, antibiotic or a pH adjuster. The compositions may be in the form of a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, soap and a cleaner.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a continuation of U.S. patent applicationSer. No. 15/322,385, filed on Dec. 27, 2016, which is a 35 U.S.C. 371national stage filing of International Application No.PCT/CA2015/050599, filed on Jun. 26, 2015, which claims benefit toProvisional Application No. 62/018,114, filed on Jun. 27, 2014, and alsoclaims benefit as a Continuation in part of application Ser. No.14/355,308, filed on Oct. 7, 2014, which is a 35 U.S.C. 371 nationalstage filing of International Application No. PCT/CA2012/050432, filedon Jun. 27, 2012, which claims benefit to Provisional Application No.61/654,490 filed Jun. 1, 2012 as well as Provisional Application No.61/641,503 filed May 2, 2012 and Provisional Application No. 61/553,506filed Oct. 31, 2011, the contents of which are hereby incorporated byreference in their entirety.

FIELD OF THE INVENTION

This invention may relate to methods of using antimicrobial andantibiofilm compositions for personal care products. It further mayrelate to methods of formulating the compositions comprising chelatingagents, zinc salts, antimicrobials and personal care acceptableexcipients for applications in personal care products. Moreparticularly, the invention may relate to an efficient method ofdelivering acceptable formulations containing two or more chelatingagents and a zinc salt for personal care.

BACKGROUND OF THE INVENTION

Contact lenses are used by an increasing number of people as means ofcorrecting vision and/or compensating for eye abnormalities. Contactlenses usually must be inserted and removed daily with cleaning anddisinfection between each wearing that requires solutions andcontainers. During wear and normal handling of contact lenses,microorganisms can adhere to the contact lenses and contaminate thestorage containers/solution. Then, microorganisms that multiplied in thestorage containers/solution can transfer to the eyes via contact lensesand become a pathogen that may cause eye infection. Various solutionshave been developed to clean these deposits and disinfect thecontainers.

Daily cleaners, comprised with various kinds of surfactants anddisinfectants is recommended for daily use to remove most deposits anddebris on contact lenses. Solutions that wet the lenses before insertionin the eye are required for contact lenses. After the contact lenses areinserted in the eye, ophthalmic solutions for rewetting, lubricating,and/or enhancing the comfort of the contact lens wearer are sometimesapplied to the eye by means of a drop dispenser. Solutions for improvingthe comfort of wearing soft contact lenses by being added directly tothe contact lens in the eye typically contain viscosity enhancingagents, lubricants, surfactants, buffers, preservatives, and salts.

Multipurpose solutions are popular because of the convenience of asingle solution for cleaning, disinfecting and conditioning contactlenses immediately prior to insertion of the lens in the eye.Multipurpose solutions are also designed for use as a wetting agent,without rinsing, meaning that the solution must be ophthalmically safefor eye contact. This limits, to some extent, the type and concentrationof both cleaning agents, biocides, antibacterials, and antibiofilmagents that can be employed in the solution as a preservative ordisinfectant as these tend to be irritating to the eye. Additionally,the surface active agents must not inhibit the wetting or conditioningfunction of the solution.

There is, therefore, a need for a composition with improvedantibacterial and antibiofilm properties while maintaining or increasingthe biocidal efficacy of the product without adversely affecting comfortor safety in terms of the level of toxicity to eye tissue. It is alsodesirable to have a composition that can be utilized as an eye drop, aneyewash solution, a contact lens care solution or a cleaning solution, astoring solution, a disinfectant, a cleaning-storing solution, and acleaning disinfecting-storing solution.

Pedicure, manicure, and podiatry instruments, such as those for cleaningand scrubbing the feet and hands and containers for soaking the feet andhands, are typically reused many times for many different clients. Toprevent the spread of bacteria and fungus, biocides, includingantibacterials and antibiofilm solutions must be strong enough to beeffective against a wide variety of bacteria, without adverselyaffecting comfort or safety of the client and the podiatrist ormanicurist, in terms of the level of toxicity.

SUMMARY OF THE INVENTION

The instant invention may provide compositions and methods forprevention, decontamination or treatment of personal care products,including eye drops, eyewash solution, contact lens care solution,contact lens cleaning solution, contact lens storing solution, contactlens disinfectant, contact lens cleaning-storing solution, and contactlens cleaning disinfecting-storing solution, contact lens containers,contact lenses, as well as podiatric, manicure and pedicure solutions,gels, creams, jellies, powders, pastes, lotions, soaps and cleaners.

One embodiment of the invention may provide a composition comprising (a)one or more chelating agents, and (b) one or two metal ion salts.

In another embodiment, a composition of the invention comprises: (a) asmall amount of at least two chelating agents, (b) a small amount of atleast one metal ion salt, wherein the amount of each of components (a)and (b) is sufficient to form an effective anti-infective compositionagainst bacterial infections in the personal care products.

In yet another embodiment, a composition of the invention comprises: (a)a small amount of at least two chelating agents, (b) a small amount ofat least one metal ion salt, and (c) personal care acceptableexcipients.

Still another embodiment of the invention may provide an anti-infectivecomposition comprising two chelating agents and one or two metal ionsalts that are effective against bacteria and fungi causing infectionsthrough the personal care products.

The compositions of the invention may be for use against one or moreinfection-associated bacteria or yeasts selected from the groupconsisting of Methicillin-resistant Staphylococcus aureus (MRSA),Staphylococcus epidermidis, Coagulase negative staphylococci (CoNS),Vancomycin resistant Enterococci (VRE), Carbapenem resistant Klebsiellapneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Methicillinresistant Staphylococcus pseudintermedius (MRSP), Malasseziapachydermatis, Salmonella typhimurium, Escherichia coli O157:H7, Candidaalbicans, Listeria monocytogenes, Campylobacter jejuni, Bacillus spp.,Streptococcus agalactiae, Streptococcus uberis, Esherichia coli,Salmonella choleraesuis, Stenotrophomonas maltophilia, Enterococcusfaecalis, Proteus mirabilis, Klebsiella spp., Enterobacter spp., andCitrobacter spp.

A further embodiment of the invention may provide an anti-infectivecomposition comprising at least two chelating agents and one are twometal ion salts that are for use against bacteria and yeasts found in orwith the personal care products.

In an embodiment, the chelating agent is between about 5000 mg/L andabout 50000/L of the composition. In an embodiment, the metal ion saltis between about 1000 mg/L and about 10000 mg/L of the composition.

The chelating agents may be selected from the group consisting of EDTA,EGTA, DTPA, EDDHA, IDA, CDTA, HEDTA, HEIDA, NTA, sodium citrate,potassium citrate, ovotransferrin and lactoferrin. The metal ion saltsmay be selected from the group consisting of zinc chloride, zinclactate, zinc citrate, zinc gluconate, zinc sulfate zinc acetate, silverion or silver sulfadiazine, silver sulfate, silver nitrate, and silvercarbonate.

In another embodiment, the chelating agents are EDTA and sodium citrate,and metal ion salt is zinc chloride or zinc sulfate. The EDTA may bepresent at about 10 mg/ml and sodium citrate may be present at about 10mg/ml. The zinc chloride or zinc lactate may be present at about 1mg/ml.

The composition may further comprise one or more ingredients selectedfrom the group consisting of: water, citrate buffer, citric acid,stabilizing agent, a flavoring agent, vitamins, minerals, herbals, asurfactant, an antimicrobial peptide, an antimicrobial and a pHadjuster. The antimicrobial preservatives can be selected from potassiumsorbate, potassium benzoate, sodium benzoate and benzoic acid, and can,in particular be used in contact lens cleaning and disinfectingsolutions. The antimicrobial preservative can be in a concentrationranging from 0.25 g/L to 3 g/L.

The invention may also teach methods of preparing a suitable formulationfor use with the personal care products in a variety of ways, forexample in a disinfecting solution, a lotion, cream, a gel, a spray, athermoreversible gel spray, and a paste.

The invention further may teach methods of preparing suitableformulations for treating or impregnating personal care products,including contact lenses, contact lens containers, and manicure,pedicure and podiatry tools and containers.

The formulations can also include natural or synthetic flavorings andcoloring agents. Thickening agents can also be added to compositions ofthe invention such as guar gum, carbopol, polyethylene glycol, pluronicF-127, sodium alginate, carboxymethyl cellulose, xanthan gum and otherpersonal care acceptable thickening agents.

Other formulations will be readily apparent to one skilled in the art. Acomposition of the invention can include antibiofilm enzymes (cellulase,beta-N-acetylgluconase, DispersinB®, papain, DNase 1, etc.),antimicrobial peptides, antibiotics (gentamicin, ciprofloxacin,ampicillin, cefamendole nafate, rifambicin, etc.), antimicrobials(triclosan, chlorhexidine, quaternary ammonium compounds, silver, silversalts, etc.) and other antibiofilm compounds.

The invention may also teach the use of liposomal or nanoparticledelivery systems that enhance the stability and efficacy ofanti-infective compounds in the compositions.

The invention may also teach personal care products treated orimpregnated with a composition of the invention, such as a contact lens,a contact lens container, a hand washing container, a hand or footscrubber, and a foot washing container.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone and in combinationon methicillin-resistant Staphylococcus aureus (MRSA) growth and biofilmformation

FIG. 2 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone and incombination on methicillin-resistant Staphylococcus pseudintermedius(MRSP) growth and biofilm formation

FIG. 3 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone and in combinationon Pseudomonas aeruginosa growth and biofilm formation

FIG. 4 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.062 mg/ml) and ZnCl₂ (0.1 mg/ml) alone and incombination on Listeria monocytogenes growth and biofilm formation

FIG. 5 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂ and EDTA+ZnCl₂ combinations onmethicillin-resistant Staphylococcus aureus (MRSA) growth and biofilmformation

FIG. 6 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onmethicillin-resistant Staphylococcus pseudintermedius (MRSP) growth andbiofilm formation

FIG. 7 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml), and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onPseudomonas aeruginosa growth and biofilm formation

FIG. 8 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onSalmonella choleraesuis ATCC 10708 growth and biofilm formation

FIG. 9 is a bar graph showing the inhibitory effect of sodium citrate (3mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onEscherichia coli O157:H7 growth and biofilm formation

FIG. 10 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and incombination on Escherichia coli O157:H7 growth and biofilm formation

FIG. 11 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onStaphylococcus epidermidis growth and biofilm formation

FIG. 12 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onCoagulase-negative Staphylococci (CoNS-42) growth and biofilm formation

FIG. 13 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onStreptococcus agalactiae ATCC 12386 growth and biofilm formation

FIG. 14 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onKlebsiella pneumoniae growth and biofilm formation

FIG. 15 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onAcinetobacter baumannii growth and biofilm formation

FIG. 16 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onStenotrophomonas maltophilia growth and biofilm formation

FIG. 17 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onVancomycin-resistant Enterococci (VRE) growth and biofilm formation

FIG. 18 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onEnterococcus faecalis growth and biofilm formation

FIG. 19 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onProteus mirabilis growth and biofilm formation

FIG. 20 is a bar graph showing the inhibitory effect of sodium citrate(3 mg/ml), EDTA (0.25 mg/ml) and ZnCl₂ (0.1 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onCandida albicans growth and biofilm formation

FIG. 21 is a bar graph showing the inhibitory effect of sodium citrate(1.5 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.05 mg/ml) alone, and sodiumcitrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations onMalassezia pachydermatis growth and biofilm formation

FIG. 22 is a bar graph showing the inhibitory effect of sodium citrate(1.5 mg/ml), EDTA (0.125 mg/ml) and ZnCl₂ (0.05 mg/ml) alone and incombination on Malassezia pachydermatis growth and biofilm formation

DETAILED DESCRIPTION OF THE INVENTION Definitions

The term “antimicrobial” refers to a compound or a composition thatkills or inhibits or stops the growth of microorganisms, including, butnot limited to bacteria and yeasts.

The term “biofilm” refers to a structured community of microorganismsenclosed in a self produced extracellular polymeric matrix, and attachedto a biotic or abiotic surface. Bacteria in a biofilm can be 1000 timesmore resistant to antibiotics/antimicrobials compared to theirplanktonic (free living) counterparts.

The term “biofilm formation” refers to the attachment of microorganismsto surfaces and the subsequent development of multiple layers of cells.

The term “antibiofilm’ refers to inhibition of microbial biofilmformation and disruption or dispersal of preformed biofilms.

The term “infection” refers to the invasion and multiplication ofmicroorganisms such as bacteria, viruses, and parasites that are notnormally present within the body. An infection may cause no symptoms andbe subclinical, or it may cause symptoms and be clinically apparent.Microorganisms that live naturally in the body are not consideredinfections.

The term “personal care product” refers to ophthalmic products,including eye drops, eyewash solution, contact lens care solution,contact lens cleaning solution, contact lens storing solution, contactlens disinfectant, contact lens cleaning-storing solution, and contactlens cleaning disinfecting-storing solution, contact lens containers,contact lenses, as well as podiatric, manicure and pedicure solutions,gels, creams, jellies, powders, pastes, lotions, soaps and cleaners, aswell as hand washing containers, hand and foot scrubbers, cuticlesoaking solutions, and foot washing containers.

The term “disinfectants” refers to substances that are applied tonon-living objects to destroy microorganisms that are living on theobjects. Disinfection does not necessarily kill all microorganisms,especially resistant bacterial spores; it is less effective thansterilization, which is an extreme physical and/or chemical process thatkills all types of life. Disinfectants are different from otherantimicrobial agents such as antibiotics, which destroy microorganismswithin the body, and antiseptics, which destroy microorganisms on livingtissue. Disinfectants are also different from biocides—the latter areintended to destroy all forms of life, not just microorganisms.Disinfectants work by destroying the cell wall/membrane of microbes orinterfering with metabolism and growth.

The term “inhibition” refers to at least a decrease of the personal careproducts-associated bacterial growth and biofilm formation.

The term “prevention” refers to at least preventing a conditionassociated with bacteria occurring in a mammal, particularly when themammal is found to be predisposed to having the condition but has notyet been diagnosed as having it.

A “preventative amount” as used herein includes a prophylactic amount,for example, an amount effective for preventing or protecting athepersonal care products. By administering a peptide suitable for use inmethods of the invention concurrently with an antimicrobial, the peptideand/or the antimicrobial may be administered in a dosage amount that isless than the dosage amount required when the antimicrobial isadministered as a sole active ingredient. By administering lower dosageamounts of active ingredient, side effects associated therewith could bereduced.

The term “metal ion salt” refers to salt of a metal ion such as zincchloride, zinc lactate, zinc citrate, zinc gluconate, zinc sulfate zincacetate, silver ion or silver sulfadiazine, silver sulfate, silvernitrate, and silver carbonate.

The present invention may teach anti-infective compositions offeringantimicrobials and antibiofilm activity, containing combinations ofchelating agents with other antimicrobial agents, such as, for example,antimicrobials/antibiofilm compounds, metal ion salts with gellingagents, surfactants or stabilizing agents.

Novel compositions that combine chelating agents together with metal ionsalts such that lesser quantities of chelating agents and/or metal ionsalts than would normally be necessary for an antimicrobial compositionare used to achieve significant bacterial growth and biofilm inhibition.Higher concentrations of these compounds can be used if it is desiredfor certain applications.

The amount of chelating agents to be used in the antimicrobialcomposition of this invention can be between 10000 to 100000 mg/L. Thehigher end of this stated range might be used to prepare a concentratedproduct that would be diluted prior to use. For non-concentratedproducts, the amount of to be used in this invention is preferablybetween about 5000 to 10000 mg/L. Preferably, the range is between about1000 to 5000 mg/L.

The amount of chelating agents to be used should be between about 1000to 5000 mg/L. The higher end of this range might apply if thecompositions were formulated as a concentrate. For non-concentratedproducts, the amount of chelating agent to be used in this invention ispreferably between about 500 to 5000 mg/L. Preferably, the range isbetween about 1000 to 3000 mg/L, more preferably between about 2000 to3000 mg/L.

For less concentrated solutions, such as for ophthalmic use, thedisodium EDTA may be between about 10 mg/L-50 mg/L of the composition,sodium citrate may be between about 100 mg/L-500 mg/L of thecomposition, and zinc chloride or zinc citrate may be between about 1mg/L-10 mg/L.

Preparation

By one method, if a two-component composition is formed containing oneor two chelating agents and a metal ion salt, these compounds can becombined in the following manner: With good stirring, a chelating agentcan be dissolved in water, followed by a metal ion salt. It should benoted, however, that the addition order can be reversed.

Additionally, antimicrobials/antimicrobial peptides, antibiotics,antibiofilm compounds, quaternary ammonium compounds and surfactantsalso may be advantageously combined with chelating agents in anantimicrobial composition. A composition of the invention comprises: (a)a small amount of at least one or two chelating agent; (b) a smallamount of a metal ion salt or iron-sequestering glycoprotein orantimicrobial peptide or an antibiotic or an antibiofilm compound; and(c) a sparing amount of at least one compound from the group consistingof a stabilizing agent and/or a gelling agent and/or a surfactant,wherein, the amount of each of component (a), (b) and (c) is sufficientto form, in combination, an effective anti-infective composition for thepersonal care products.

The concentration of active components in the compositions may vary asdesired or necessary to decrease the amount of time the composition ofthe invention is used for the personal care products. These variationsin active components concentration are easily determined by personsskilled in the art.

Compositions

The present invention may include unique and enhanced anti-infectivecompositions for the personal care products comprising at least twochelating agents and one metal ion salt.

In an embodiment, two chelating agents and a metal ion salt containingcomposition includes an antimicrobial compound. The chelating agents anda metal ion salt containing composition with an antimicrobialand/antibiofilm compound has an enhanced inhibitory effect on thepersonal care products-associated bacterial growth and biofilmformation. In an embodiment of the invention, an enhancedantimicrobial-antibiofilm composition comprises at least one or twochelating agents, one metal ion salt and one or more antimicrobialagents comprising antiseptics (e.g., triclosan, chlorhexidine salt,cetylpyridinium chloride, etc.), antibiotics and bacteriocins (e.g.,nisin, epidermin, gallidennin, cinnamycin, duramycin, lacticin 481,etc.), and iron-sequestering glycoproteins (ovotransferrin, lactoferrinand serrotransferrin). Additionally, the personal care productcompositions may comprise ingredients such as citrate (e.g., citricacid, zinc citrate, sodium citrate, potassium citrate, etc.), minerals(e.g., mineral salts such as zinc chloride, zinc gluconate, zinclactate, zinc citrate, zinc sulfate, zinc acetate, silver, silversulfate, silver sulfadiazine, silver nitrate, silver carbonate, etc.),and triterpenoids (e.g., oleanolic acid and ursolic acid) and chitosan.

In an embodiment, a composition comprises an antibiotic and one or twochelating agents and also one metal ion salt. Antibiotics are wellknown. Groups of antibiotics include, but are not limited to, β-lactaminhibitors (e.g., penicillin, ampicillin, amoxicillin, methicillin,etc.), cephalosporins (e.g., cephalothin, cephamycin, etc.),aminoglycosides (e.g., streptomycin, tobramycin, etc.), polyenes (e.g.,amphotericin, nystatin, etc.), macrolides (e.g., erythromycin, etc.),tetracyclines (e.g., tetracycline, doxycycline, etc.), nitroimidazole(e.g., metronidazole), quinolones (e.g., nalidixic acid), rifamycins(e.g., rifampin), and sulfonamides (e.g., sulfanilamide), nitroaromatics(e.g., chloramphenicol) and pyridines (e.g., isoniazid).

In an embodiment, a composition comprises an antiseptic, one or twochelating agents and one metal ion salt. Antiseptics are agents thatkill or inhibit the growth of microorganisms on the external surfaces ofthe body. Antiseptics include, but are not limited to, triclosan,chlorhexidine salt, and cetylpyridinium chloride.

In an embodiment, a composition comprises an antibiofilm compound, oneor two chelating agents and a metal ion salt. Antibiofilm compoundsinclude, but not limited to, DisperinB, DNase I, Proteinase K, apyrase,cis-2-decenoic acid, alginate lyase, lactoferrin, gallium, cellulase,and 5-fluorouracil.

In an embodiment, a composition is effective for inhibiting growth andbiofilm formation in the personal care products. The composition is alsoeffective in disrupting or dispersing preformed biofilms, which makesbiofilm-embedded bacteria more susceptible to antimicrobial killing.Under appropriate environmental conditions, such as moisture and pH,infections can be modulated using embodiments of the invention.

An embodiment of the invention may also include other personal careacceptable vehicles, diluents, and additives such as antioxidants,anti-inflammatory compounds, vitamins, tissue degrading enzymes, buffersand solutes that render the formulation isotonic in the intendedrecipient; and aqueous and non-aqueous sterile suspensions which mayinclude suspending agents, surfactants and thickening agents.

Personal Care Formulations

A composition of the invention may be added to a variety of formulationssuitable for applying/delivering the composition to the personal careproducts, including, but not limited to, disinfecting solutions,lotions, creams, gels, sprays. To provide such formulations, acomposition of this invention is combined with one or more personal careacceptable excipients.

Formulations including, but not limited to, personal care acceptablecompositions comprising one or two chelating agents and a metal ion saltin combination with an antiseptic, an antibiotic, an antimicrobial, aniron-sequestering glycoprotein, a bacteriocin, extracellular matrix orchitosan can be prepared by any known method.

In general, methods of manufacturing anti-infective compositions maycomprise combining a personal care acceptable carrier and an effectiveamount of both chelating agents and a metal ion salt with an antiseptic,an antibiotic, a bacteriocin, an antimicrobial peptide or chitosan.

A variety of carriers and excipients can be used to formulate anembodiment of this invention and are well known. Such personal careacceptable vehicles include, but are not limited to, water, ethanol,humectants such as polypropylene glycol, glycerol and sorbitol, gellingagents such as cellulose derivatives, polyoxypropylene/polyoxyethyleneblock copolymers, carboxy methyl cellulose, pluronic F-127, sodiumalginate, polyethylene glycol, thickening agents such as Carbopol™ 934.

Method of Treatment

For use in treating or disinfecting personal care products, preferredconcentration range of ingredients may include:

-   (i) Sodium Citrate: (a) 50,000 mg/L-100,000 mg/L, (b) 25,000    mg/L-50,000 mg/L, (c) 10,000 mg/L-25,000 mg/L, (d) 5,000 mg/L-10,000    mg/L, & (e) 1,000 mg/L-5,000 mg/L.-   (ii) Disodium EDTA: (a) 10,000 mg/L-25,000 mg/L, (b) 5,000    mg/L-10,000 mg/L, (c) 1,000 mg/L-5,000 mg/L, (d) 500 mg/L-1,000    mg/L, & (e) 100 mg/L-500 mg/L-   (iii) Zinc Chloride: (a) 1,000 mg/L-5,000 mg/L, (b) 500 mg/L-1,000    mg/L, (c) 100 mg/L-500 mg/L, and (d) 10 mg/L-100 mg/L.

In one embodiment, one or more chelating agents and a metal ion salttogether is formulated as personal care acceptable medicament asdescribed herein comprising a carrier and an effective amount ofcomposition comprising one or more chelating agents and a metal ion saltas active ingredients.

In a further embodiment of the invention, an enhanced personal careproduct does not present any antibiotic resistance concerns andbio-compatibility/safety issues. Also, the composition of this inventioncomprising one or two chelating agents (EDTA and sodium citrate) and ametal ion salt (zinc chloride or zinc sulfate or zinc lactate) has GRAS(Generally Recognized as Safe) status and all these ingredients are foodas well as feed additives.

The present invention may be better understood with reference to thefollowing examples. These examples are intended to be representative ofspecific embodiments of the invention, and are not intended as limitingthe scope of the invention.

EXAMPLES Example 1: Inhibitory Effect of Sodium Citrate, EDTA and ZincChloride Alone and in Combination on Methicillin-ResistantStaphylococcus aureus (MRSA) Growth and Biofilm Formation

An overnight broth culture of S. aureus was grown in TSB and used asinoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and together (Sodium chloride+EDTA+Zinc chloride) wereinoculated and incubated at 37° C. for 24 hours. Growth of planktoniccells based on absorbance at 600 nm using Labsystems Multiskan Ascentmicroplate reader was determined. Biofilm was measured by discarding themedia in the wells, rinsing the well three times with water, andstaining the bound cells with crystal violet. The dye was thensolubilized with 33% acetic acid, and absorbance at 630 nm wasdetermined using a microtiter plate reader. A composition, comprisingsodium citrate, EDTA and zinc chloride showed an enhanced inhibitoryeffect on biofilm formation, as compared to sodium citrate, or EDTA, orzinc chloride alone (FIG. 1 ).

Example 2: Inhibitory Effect of Sodium Citrate, EDTA and Zinc ChlorideAlone, and in Combination on Methicillin-Resistant Staphylococcuspseudintermedius (MRSP) Growth and Biofilm Formation

An overnight broth culture of methicillin resistant S. pseudintermediuswas grown in TSB and used as inoculum. 96-well microplates containingTSB in the absence and the presence of each compound (sodium citrate orEDTA or Zinc chloride) separately and together (Sodiumchloride+EDTA+Zinc chloride) were inoculated and incubated at 37° C. for24 hours. Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. Acomposition, comprising sodium citrate, EDTA and zinc chloride showed anenhanced inhibitory effect on biofilm formation, as compared to sodiumcitrate, or EDTA, or zinc chloride alone (FIG. 2 ).

Example 3: Inhibitory Effect of Sodium Citrate, EDTA, and Zinc ChlorideAlone, and in Combination on Pseudomonas aeruginosa Growth and BiofilmFormation

An overnight broth culture of P. aeruginosa was grown in TSB and used asinoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and together (Sodium chloride+EDTA+Zinc chloride) wereinoculated and incubated at 37° C. for 24 hours. Growth of planktoniccells based on absorbance at 600 nm using Labsystems Multiskan Ascentmicroplate reader was determined. Biofilm was measured by discarding themedia in the wells, rinsing the well three times with water, andstaining the bound cells with crystal violet. The dye was thensolubilized with 33% acetic acid, and absorbance at 630 nm wasdetermined using a microtiter plate reader. A composition, comprisingsodium citrate, EDTA and zinc chloride showed an enhanced inhibitoryeffect on biofilm formation, as compared to sodium citrate, or EDTA, orzinc chloride alone (FIG. 3 ).

Example 4: Inhibitory Effect of Sodium Citrate, EDTA, and Zinc ChlorideAlone and in Combination on Listeria monocytogenes Growth and BiofilmFormation

An overnight broth culture of L. monocytogenes was grown in TSB and usedas inoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and together (Sodium chloride+EDTA+Zinc chloride) wereinoculated and incubated at 37° C. for 24 hours. Growth of planktoniccells based on absorbance at 600 nm using Labsystems Multiskan Ascentmicroplate reader was determined. Biofilm was measured by discarding themedia in the wells, rinsing the well three times with water, andstaining the bound cells with crystal violet. The dye was thensolubilized with 33% acetic acid, and absorbance at 630 nm wasdetermined using a microtiter plate reader. A composition, comprisingsodium citrate, EDTA and zinc chloride showed an enhanced inhibitoryeffect on biofilm formation, as compared to sodium citrate, or EDTA, orzinc chloride alone (FIG. 4 ).

Example 5: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Methicillin-Resistant Staphylococcus aureus [MRSA]Growth and Biofilm Formation

An overnight broth culture of S. aureus (MRSA) was grown in TSB and usedas inoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and Sodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA and Sodium citrate+ZnCl₂ combinations showed anenhanced inhibitory effect on biofilm formation, as compared to sodiumcitrate, or EDTA, or zinc chloride alone (FIG. 5 ).

Example 6: Effect of Sodium Citrate, EDTA, and ZnCl₂ Alone, and SodiumCitrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂ Combinations onMethicillin Resistant Staphylococcus pseudintermedius (MRSP) Growth andBiofilm Formation

An overnight broth culture of MRSP was grown in TSB and used asinoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and Sodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinationsshowed an enhanced inhibitory effect on biofilm formation, as comparedto sodium citrate, or EDTA, or zinc chloride alone (FIG. 6 ).

Example 7: Inhibitory Effect of Sodium Citrate, EDTA, and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Pseudomonas aeruginosa Growth and Biofilm Formation

An overnight broth culture of P. aeruginosa was grown in TSB and used asinoculum. 96-well microplates containing TSB in the absence and thepresence of each compound (sodium citrate or EDTA or Zinc chloride)separately and Sodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA, and EDTA+ZnCl₂ combinations showed an enhancedinhibitory effect on biofilm formation, as compared to sodium citrate,or EDTA, or zinc chloride alone (FIG. 7 ).

Example 8: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Salmonella choleraesuis ATCC 10708

An overnight broth culture of S. choleraesuis ATCC 10708 was grown inTSB and used as inoculum. 96-well microtiter plates containing TSB inthe absence and the presence of each compound (sodium citrate or EDTA orZinc chloride) separately and sodium citrate+EDTA, sodium citrate+ZnCl₂,and EDTA+ZnCl₂ combinations were inoculated and incubated at 37° C. for24 hours. Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 8).

Example 9: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Escherichia coli O157:H7

An overnight broth culture of E. coli O157:H7 was grown in TSB and usedas inoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinationsshowed an enhanced inhibitory effect on biofilm formation, as comparedto sodium citrate, or EDTA or zinc chloride alone (FIG. 9 ).

Example 10: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and in Combination on Escherichia coli O157:H7

An overnight broth culture of E. coli O157:H7 was grown in TSB and usedas inoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and together (Sodium chloride+EDTA+Zinc chloride) wereinoculated and incubated at 37° C. for 24 hours. Growth of planktoniccells based on absorbance at 600 nm using Labsystems Multiskan Ascentmicroplate reader was determined. Biofilm was measured by discarding themedia in the wells, rinsing the well three times with water, andstaining the bound cells with crystal violet. The dye was thensolubilized with 33% acetic acid, and absorbance at 630 nm wasdetermined using a microtiter plate reader. A composition comprisingsodium citrate, EDTA, and ZnCl₂ showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA, or zincchloride alone (FIG. 10 ).

Example 11: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Staphylococcus epidermidis

An overnight broth culture of S. epidermidis was grown in TSB and usedas inoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 11).

Example 12: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Coagulase-Negative Staphylococci (CoNS-42)

An overnight broth culture of CoNS-42 was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 12).

Example 13: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Streptococcus agalactiae ATCC 12386

An overnight broth culture of S. agalactiae was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 13).

Example 14: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Klebsiella pneumoniae

An overnight broth culture of K. pneumoniae was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 14).

Example 15: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Acinetobacter baumannii

An overnight broth culture of A. baumannii was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 15).

Example 16: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Stenotrophomonas maltophilia

An overnight broth culture of S. maltophilia was grown in TSB and usedas inoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 16).

Example 17: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Vancomycin-Resistant Enterococci (VRE)

An overnight broth culture of VRE was grown in TSB and used as inoculum.96-well microtiter plates containing TSB in the absence and the presenceof each compound (sodium citrate or EDTA or Zinc chloride) separatelyand sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 17).

Example 18: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Enterococcus faecalis

An overnight broth culture of E. faecalis was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 18).

Example 19: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Proteus mirabilis

An overnight broth culture of P. mirabilis was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 19).

Example 20: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Candida albicans

An overnight broth culture of C. albicans was grown in TSB and used asinoculum. 96-well microtiter plates containing TSB in the absence andthe presence of each compound (sodium citrate or EDTA or Zinc chloride)separately and sodium citrate+EDTA, sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations were inoculated and incubated at 37° C. for 24 hours.Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. ASodium citrate+EDTA combination showed an enhanced inhibitory effect onbiofilm formation, as compared to sodium citrate, or EDTA alone (FIG. 20).

Example 21: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Alone,and Sodium Citrate+EDTA, Sodium Citrate+ZnCl₂, and EDTA+ZnCl₂Combinations on Malassezia pachydermatis

An overnight broth culture of Malassezia pachydermatis was grown inSabouraud Dextrose Broth and used as inoculum. 96-well microtiter platescontaining TSB in the absence and the presence of each compound (sodiumcitrate or EDTA or Zinc chloride) separately and sodium citrate+EDTA,sodium citrate+ZnCl₂, and EDTA+ZnCl₂ combinations were inoculated andincubated at 37° C. for 24 hours. Growth of planktonic cells based onabsorbance at 600 nm using Labsystems Multiskan Ascent microplate readerwas determined. Biofilm was measured by discarding the media in thewells, rinsing the well three times with water, and staining the boundcells with crystal violet. The dye was then solubilized with 33% aceticacid, and absorbance at 630 nm was determined using a microtiter platereader. A Sodium citrate+EDTA, Sodium citrate+ZnCl₂, and EDTA+ZnCl₂combinations showed an enhanced inhibitory effect on biofilm formation,as compared to sodium citrate, or EDTA or zinc chloride alone (FIG. 21).

Example 22: Inhibitory Effect of Sodium Citrate, EDTA and ZnCl₂ Aloneand in Combination on Malassezia pachydermatis

An overnight broth culture of Malassezia pachydermatis was grown inSabouraud Dextrose Broth and used as inoculum. 96-well microtiter platescontaining TSB in the absence and the presence of each compound (sodiumcitrate or EDTA or Zinc chloride) separately and together (Sodiumchloride+EDTA+Zinc chloride) were inoculated and incubated at 37° C. for24 hours. Growth of planktonic cells based on absorbance at 600 nm usingLabsystems Multiskan Ascent microplate reader was determined. Biofilmwas measured by discarding the media in the wells, rinsing the wellthree times with water, and staining the bound cells with crystalviolet. The dye was then solubilized with 33% acetic acid, andabsorbance at 630 nm was determined using a microtiter plate reader. Acomposition comprising sodium citrate, EDTA, and ZnCl₂ showed anenhanced inhibitory effect on biofilm formation, as compared to sodiumcitrate, or EDTA, or zinc chloride alone (FIG. 22 ).

We claim:
 1. A composition for inhibiting growth of bacteria andbiofilm, the composition comprising: (a) water; (b) one or morechelating agents selected from the group consisting of disodium ortetrasodium EDTA at a concentration of at least about 62 mg/L; (c) oneor more chelating agents selected from the group consisting of sodiumcitrate and potassium citrate, at a concentration of about 3,000 mg/L;and (d) a zinc salt selected from the group consisting of zinc chloride,zinc gluconate, zinc lactate, zinc citrate, zinc sulfate, and zincacetate at a concentration of about 100 mg/L.
 2. The composition ofclaim 1, wherein the zinc salt is zinc chloride or zinc citrate.
 3. Thecomposition of claim 1, further comprising an antimicrobial preservativeselected from one or more of potassium sorbate, potassium benzoate,sodium benzoate and benzoic acid.
 4. The composition of claim 1, furthercomprising one or more ingredients selected from the group consistingof: water, a buffer, a stabilizing agent, a gelling agent, a surfactant,a herbal, a vitamin, a mineral, an extra cellular matrix, anantimicrobial, an antibiotic, and a pH adjuster.
 5. The composition ofclaim 1 prepared as one or more of a disinfecting solution, a dipsolution, a lotion, a cream, an ointment, a gel, and a spray.
 6. Thecomposition as claimed in claim 1, wherein the composition comprises aliposome or nanoparticle or a suitable device delivery system.
 7. Thecomposition as claimed in claim 1, further comprising an anti-infectivecompound selected from the group consisting of glycoside hydrolase ofAggregatibacter actinomycetemcomitans, alginate lyase, nisin,lactoferricin, serotransferrin, ovotransferrin, ovalbumin, ovomucoid,protamine sulfate, chlorhexidine, cetylpyridinium chloride, triclosan,silver sulfadiazine, benzalkonium chloride, hydrogen peroxide, citricacid, potassium citrate, 5-fluorouracil, cis-2-decenoic acid, DNase I,proteinase K, silver, gallium, silver, bacteriocins and antimicrobialpeptides.
 8. The composition as claimed in claim 1 further comprisingone or more of viscosity enhancing agents, lubricants, surfactants,buffers, preservatives, and salts.
 9. The composition as claimed inclaim 1, wherein the composition is selected from a solution, a gel, acream, a jelly, a powder, a paste, a lotion, a soap and a cleaner.
 10. Amethod of preventing or treating ophthalmic biofilm growth, the methodcomprising administering the composition of claim 1 to a user.
 11. Themethod of claim 10, wherein the method further comprises administeringthe composition of claim 1 to the eye of a user.
 12. The method of claim10, wherein the method further comprises administering the compositionof claim 1 to a foot, fingernail, or toenail of a user.
 13. A personalcare device treated or impregnated with the composition of claim
 1. 14.The personal care device of claim 13, wherein the composition isselected from a solution, a gel, a cream, a jelly, a powder, a paste, alotion, a soap and a cleaner.
 15. The personal care device of claim 13,further comprising one or more of a contact lens and a contact lenscontainer.
 16. The personal care device of claim 13, further comprisingone or more of a hand washing container, a scrubber, and a foot washingcontainer.